Balaji Phosphates（BALAJIPHOS）株式概要バラジ・フォスフェート社はインドで肥料を製造・供給している。 詳細BALAJIPHOS ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績4/6財務の健全性3/6配当金0/6報酬株価収益率（ 19.6 x） Indian市場（ 23.1 x）を下回っています。過去1年間で収益は122.6%増加しました リスク分析高いレベルの非現金収入 負債は営業キャッシュフローで十分にカバーされていない 意味のある時価総額がありません ( ₹2B )Indian市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見るBALAJIPHOS Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹96.0085.1% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture01b2016201920222025202620282031Revenue ₹1.5bEarnings ₹116.2mAdvancedSet Fair ValueView all narrativesBalaji Phosphates Limited 競合他社Nova AgritechSymbol: NSEI:NOVAAGRIMarket cap: ₹2.6bAnya Polytech & FertilizersSymbol: NSEI:ANYAMarket cap: ₹2.1bSikko IndustriesSymbol: NSEI:SIKKOMarket cap: ₹1.9bIndogulf CropsciencesSymbol: NSEI:IGCLMarket cap: ₹3.9b価格と性能株価の高値、安値、推移の概要Balaji Phosphates過去の株価現在の株価₹96.0052週高値₹184.7052週安値₹78.80ベータ01ヶ月の変化-10.28%3ヶ月変化-29.41%1年変化-31.43%3年間の変化n/a5年間の変化n/aIPOからの変化29.12%最新ニュースValuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year.New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m).New Risk • Jan 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m).Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India.分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...New Risk • Nov 17New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m).最新情報をもっと見るRecent updatesValuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year.New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m).New Risk • Jan 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m).Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India.分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...New Risk • Nov 17New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m).お知らせ • Nov 14Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025分析記事 • Oct 14Some Confidence Is Lacking In Balaji Phosphates Limited's (NSE:BALAJIPHOS) P/EWith a price-to-earnings (or "P/E") ratio of 42.2x Balaji Phosphates Limited ( NSE:BALAJIPHOS ) may be sending very...お知らせ • Sep 05Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025, at 15:00 Indian Standard Time. Location: 305 utsav avenue, 12/5 usha ganj jaora compound, mp - 452001, indore India分析記事 • Aug 22Is Balaji Phosphates (NSE:BALAJIPHOS) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹173, the stock trades at a trailing P/E ratio of 51.9x. Average trailing P/E is 27x in the Chemicals industry in India.Reported Earnings • Jul 09Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses.Reported Earnings • Apr 03First half 2025 earnings releasedFirst half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024).Valuation Update With 7 Day Price Move • Mar 25Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹91.10, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 25x in the Chemicals industry in India.株主還元BALAJIPHOSIN ChemicalsIN 市場7D-3.0%0.7%0.5%1Y-31.4%-2.6%-0.7%株主還元を見る業界別リターン: BALAJIPHOS過去 1 年間で-2.6 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: BALAJIPHOSは、過去 1 年間で-0.7 % のリターンを上げたIndian市場を下回りました。価格変動Is BALAJIPHOS's price volatile compared to industry and market?BALAJIPHOS volatilityBALAJIPHOS Average Weekly Movement9.2%Chemicals Industry Average Movement7.2%Market Average Movement7.2%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.8%安定した株価: BALAJIPHOSの株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: BALAJIPHOSの weekly volatility ( 9% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1996n/aMohit Airenwww.balajiphosphates.comBalaji Phosphates 社はインドで肥料を製造・供給している。同社は、RATNAMとBPPLのブランド名で、粉末と粒状の単一過リン酸塩、亜鉛化粉末と粒状肥料、ホウ素化粉末と粒状肥料、ジンクとホウ素を強化した粒状の単一過リン酸塩、農業用硫酸ジンク七水和物、NPK粒状肥料と混合肥料を提供している。また、容量633MTまでの計量ブリッジの製造・販売も行っている。同社は1996年に設立され、インドのインドールに拠点を置く。もっと見るBalaji Phosphates Limited 基礎のまとめBalaji Phosphates の収益と売上を時価総額と比較するとどうか。BALAJIPHOS 基礎統計学時価総額₹2.28b収益（TTM）₹116.24m売上高(TTM)₹1.49b19.6xPER（株価収益率1.5xP/SレシオBALAJIPHOS は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計BALAJIPHOS 損益計算書（TTM）収益₹1.49b売上原価₹932.08m売上総利益₹555.74mその他の費用₹439.50m収益₹116.24m直近の収益報告Sep 30, 2025次回決算日該当なし一株当たり利益（EPS）4.89グロス・マージン37.35%純利益率7.81%有利子負債／自己資本比率45.7%BALAJIPHOS の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 02:55終値2026/05/21 00:00収益2025/09/30年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Balaji Phosphates Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year.
New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m).
New Risk • Jan 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m).
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India.
分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...
New Risk • Nov 17New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m).
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 26%After last week's 26% share price decline to ₹111, the stock trades at a trailing P/E ratio of 22.6x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 36% over the past year.
New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹3.54b market cap, or US$38.4m).
New Risk • Jan 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). High level of non-cash earnings (55% accrual ratio). Minor Risk Market cap is less than US$100m (₹3.06b market cap, or US$33.7m).
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹143, the stock trades at a trailing P/E ratio of 29.1x. Average trailing P/E is 23x in the Chemicals industry in India.
分析記事 • Nov 22Balaji Phosphates' (NSE:BALAJIPHOS) Earnings Aren't As Good As They AppearDespite posting strong earnings, Balaji Phosphates Limited's ( NSE:BALAJIPHOS ) stock didn't move much over the last...
New Risk • Nov 17New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (55% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹3.03b market cap, or US$34.2m).
お知らせ • Nov 14Balaji Phosphates Limited to Report First Half, 2026 Results on Nov 14, 2025Balaji Phosphates Limited announced that they will report first half, 2026 results on Nov 14, 2025
分析記事 • Oct 14Some Confidence Is Lacking In Balaji Phosphates Limited's (NSE:BALAJIPHOS) P/EWith a price-to-earnings (or "P/E") ratio of 42.2x Balaji Phosphates Limited ( NSE:BALAJIPHOS ) may be sending very...
お知らせ • Sep 05Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025Balaji Phosphates Limited, Annual General Meeting, Sep 30, 2025, at 15:00 Indian Standard Time. Location: 305 utsav avenue, 12/5 usha ganj jaora compound, mp - 452001, indore India
分析記事 • Aug 22Is Balaji Phosphates (NSE:BALAJIPHOS) Using Too Much Debt?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Valuation Update With 7 Day Price Move • Aug 21Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹173, the stock trades at a trailing P/E ratio of 51.9x. Average trailing P/E is 27x in the Chemicals industry in India.
Reported Earnings • Jul 09Full year 2025 earnings released: EPS: ₹4.34 (vs ₹3.39 in FY 2024)Full year 2025 results: EPS: ₹4.34 (up from ₹3.39 in FY 2024). Revenue: ₹1.29b (down 15% from FY 2024). Net income: ₹79.2m (up 31% from FY 2024). Profit margin: 6.2% (up from 4.0% in FY 2024). The increase in margin was driven by lower expenses.
Reported Earnings • Apr 03First half 2025 earnings releasedFirst half 2025 results: EPS: ₹2.43. Net income: ₹43.4m (up ₹43.4m from 1H 2024).
Valuation Update With 7 Day Price Move • Mar 25Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹91.10, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 25x in the Chemicals industry in India.
